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Background. Contrast-enhanced computed tomography is commonly acquired before radiofrequency catheter ablation (RFCA)
for atrial fibrillation (AFib) to guide the procedure. We analyzed pulmonary vein (PV) ostial diameter and volumes on a high-
definition 64-slice CT (HDCT) scanner in patients withAFib prior to RFCA.Methods and Results.This retrospective study included
50 patients (mean age 60.2 ± 11.4 years, 30 males) undergoing cardiac HDCT scanning before RFCA for drug refractory AFib
and 50 age-, BMI-, and sex-matched controls with normal sinus rhythm undergoing HDCT. PV ostial diameter and volume were
measured and calculated using a semiautomatic calliper tool. Total ostial PV volume was significantly increased in patients with
AFib as compared to controls (𝑃 < 0.005). Similarly, total ostial PV diameter was significantly increased in AFib compared to
controls (𝑃 < 0.001). In AFib, the largest PV volume and diameters were measured in right superior PV (𝑃 < 0.05 versus controls).
The difference in PV volume between patients and controls was most pronounced in right superior PVs (𝑃 = 0.015). Right middle
PVs were found more often in patients with AFib (16/50; 32%) than in normal subjects (7/50; 14%). Conclusion. Enlargement of PV
ostial area and enlargement of volume are frequent findings in patients with drug refractory AFib. These parameters may add to
the risk stratification for AFib recurrence following RFCA.
1. Introduction
Atrial fibrillation (AFib) is one of the most common arrhyth-
mias with an increased prevalence with advancing age
[1]. Pulmonary veins (PVs), in particular sleeves of atrial
myocardium extending into the PVs, have been recognized as
amajor source of ectopic arrhythmogenic foci initiating AFib
[2]. Pulmonary vein isolation by radiofrequency catheter
ablation (RFCA) has become an effective and safe treatment
option for selected patients with AFib [3, 4]. Accurate
assessment of the anatomy of the PVs and the dimension
of PV ostia is essential to optimize guidance of the ablation
procedure [5, 6]. Cardiac computed tomography (CT) is an
established imaging modality to visualize the posterior left
atrium and the PV anatomy before RFCA [7, 8]. Indeed, PV
ostial dimensions obtained by CT have been shown to cor-
relate with those assessed by intracardiac echocardiography
and venography [7] and introduction of high-definition CT
(HDCT) may further improve such assessment.
Pulmonary vein anatomy is considered to play an impor-
tant role in the initiation of AFib. Previous studies have
shown that left atrial and PV remodeling including geometric
alterations towards a round shape in the ostia of superior
PVs occurs in patients with successful RFCA compared to
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those with recurrence of AFib [9]. These findings suggest
that morphologic alterations of PV anatomy, in particular
enlargement of PVs, may alter PV arrythmogenicity and
facilitate the induction of AFib. Indeed, variations in PV ana-
tomy are more common in patients with AFib, and diameters
of PV ostia are known to be larger [10]. However, the assess-
ment of PV diameters may be hampered by the elliptical
shape of PV ostia, and assessment of PV ostial area and vol-
ume may overcome this geometric difficulty.
Hence, the aim of this study was to assess whether total
PV ostial diameter and volume assessed by HDCT are larger
in patients with AFib prior to RFCA compared to controls
with sinus rhythm (SR), as those parameters may provide
a noninvasive tool for risk stratification of AFib recurrence
after RFCA.
2. Methods
2.1. Patients. This retrospective study enrolled 50 consecutive
patients undergoing HDCT before RFCA for drug refractory
AFib and 50 controls matched for gender, age, and bodymass
index with normal SR who underwent clinically indicated
contrast-enhanced cardiac HDCT scanning between July
2011 and June 2012. The need to obtain written informed
consent in this study was waived by the institutional review
board (local ethics committee) since, according to Swiss law
on clinical investigations, informed consent is not required if
the nature of the study is purely observational and includes
solely clinical data collection. Indications for CT in patients
with SR were typical (𝑛 = 23) or atypical angina (𝑛 = 9),
dyspnoea (𝑛 = 3), positive stress test (𝑛 = 8), or pre-
operative risk evaluation (𝑛 = 7). Exclusion criteria for car-
diac CT examination were renal failure (glomerular filtration
rate <30mL/min), known allergy to iodine contrast material,
severe claustrophobia, and pregnancy. Baseline characteris-
tics are summarized in Table 1.
2.2. Cardiac CT Acquisition. All scans were performed on
a 64-HDCT scanner (Discovery HD 750, GE Healthcare)
with prospective electrocardiogram (ECG) triggering (75%of
RR-interval), a body surface area- (BSA-) adapted contrast
media bolus (Visipaque, GE Healthcare, 40–125mL, 3.5–
5mL/s) [11–13], and i.v. 𝛽-blockers, if needed, to achieve
a heart rate lower than 65 beats per minute and 0.4mg
sublingual nitroglycerine was administered to the control
group immediately before the study. Radiation dose was
calculated from the dose-length product using a conversion
factor of 0.014mSv/(mGy/cm) [14].The scanning parameters
included 64 × 0.625mm collimation, a rotation time of 0.35 s,
and body mass index- (BMI-) adjusted tube voltage (100–
120 kV) and current (450–700mA). The Discovery CT 750
HD scanner is a high-definition CT scanner equipped with a
Gemstone detector. Images were acquired in high resolution
mode (230 𝜇m) and reconstructed in high-definition mode
(in plane resolution 0.23 × 0.23mm, 2,496 views per rotation,
and cardiac spatial resolution 18.2 lp/cm). Images were recon-
structed by applying a blending factor of 30% of adaptive
statistical iterative reconstruction (ASiR; GE Healthcare)
according to clinical standards established in our institution.
Table 1: Patient characteristics (patient baseline and CT acquisition
characteristics).
AFib
𝑛 = 50
SR
𝑛 = 50
Male sex, number of
patients (of total) 30 (50) 30 (50)
Age (years) 60 ± 11 59 ± 10
BMI (kg/m2) 27.9 ± 4.6 27.2 ± 4.3
mSv 2.1 ± 0.3 2.0 ± 0.4
Heart rate (bpm) 55.5 ± 2.1 69.2 ± 1.2
Tube voltage (kV) 113 ± 1.2 115 ± 1.3
Tube current (mA) 645.7 ± 4.8 632.9 ± 5.0
Contrast volume (mL) 102.3 ± 1.8 89.3 ± 2.4
Beta-blocker (mg) 7.5 ± 1.4 0
Values are given as mean ± standard deviation (SD). BMI: body mass index;
SR: sinus rhythm; AFib: atrial fibrillation.
ASiR is a modified iterative reconstruction algorithm that
models the photon statistics in X-ray attenuation, resulting
in significant noise reduction, which improves image quality
and allows reduction in radiation dose.
2.3. Cardiac CTAnalysis. Images with a reconstruction inter-
val of 0.6mm were transferred to a workstation (Advantage
AW 4.4 workstation, GE Healthcare) with 3D capabilities.
Since it can be challenging to identify the ostium in 3D
reconstructions, the PVostial dimensionswere first evaluated
using a 2-dimensional viewing mode assisted by oblique
and curvedmultiplanar reconstructions (Figure 4).WhenPV
ostia had been viewed and clearly identified, measurement
of minimal and maximal PV diameter and area at the level
of the ostium was obtained by using an automatic tool.
Then, 3D volume-rendered images were used for depiction of
pulmonary vein anatomical variants and branching patterns.
Normal anatomy was defined as presence of two septal or
right and two lateral or left separate PV ostia. A left common
ostium (LCO) was defined when the superior and inferior
left PV joined >5mm before entering the left atrium. A
right common ostium (RCO) was defined when the superior
and inferior right PV joined >5mm before entering the left
atrium. A right middle pulmonary vein (RMPV) was defined
as accessory, separate ostium for the middle-lobe vein. Other
anatomical variants were not observed in our population.The
volume was then measured and automatically calculated in
3D reconstruction from the previously determined point of
inflection between the PV and atrial wall along the course
of the PV to the midpoint of the PV 1 cm distally of the
ostium. To standardize the analysis, images were displayed
with a fixed window level at 100HU and a window width
at 800HU. Similarly, the LA area was traced by using 3D
volume-rendered images and semiautomated circumference
measurement by excluding PVs at their ostia and the LA
appendage at its base. LA volume was calculated by using
an automatic tool. Volumes were reported independently and
also indexed to body surface area.
Cardiology Research and Practice 3
AFibControl
15
10
5
0
To
ta
l o
sti
al
 p
ul
m
on
ar
y 
ve
in
 v
ol
um
e (
m
m
3
)
∗
P = 0.005, n = 50
×10
3
(a)
AFibControl
To
ta
l o
sti
al
 p
ul
m
on
ar
y 
ve
in
 d
ia
m
et
er
 (m
m
)
125
100
75
50
25
Maximal ostial diameter
Minimal ostial diameter
∗
∗
P < 0.001, n = 50
(b)
Figure 1: (a) Boxplots of total pulmonary vein (PV) volume (mm3) in patients with atrial fibrillation (AFib) compared to controls with sinus
rhythm (SR). (b) Total ostial pulmonary vein (PV) diameter (mm) in patients with atrial fibrillation (AFib) compared to healthy controls
with sinus rhythm (SR). Data are presented as mean ± SD; ∗𝑃 < 0.05.
2.4. Statistical Analysis. Quantitative variables were express-
ed as mean ± SD or mean ± SEM and categorical variables
were expressed as frequencies or percentages. Normality
was tested with the Kolmogorov-Smirnov test. Comparisons
between the two groupswere performed using Student’s 𝑡-test
for continuous variables with normal distributions and the
Mann-Whitney𝑈 test for continuous variables with nonnor-
mal distributions. All analyses were performed with statistics
software (SPSS version 20.0 for Microsoft Windows). A two-
tailed 𝑃 value of <0.05 was deemed significant.
3. Results
3.1. Patient Characteristics. Cardiac HDCT scans from 50
consecutive patients (mean age 60.1 ± 11.4 years, mean BMI
27.3 ± 4.3 kg/m2, 30 males) undergoing RFCA for drug
refractory AFib and from 50 controls with normal sinus were
analyzed. Controls were adequately matched for gender, age,
and body mass index (𝑃 = NS). A total contrast amount
of 102.3 ± 1.8mL (AFib) and 89.3 ± 2.4mL (controls) was
administered (Table 1; 𝑃 = NS). Eight (16%) patients in the
AFib group were with AFib during image acquisition. The
average effective radiation dose was 2.1 ± 0.3mSv (AFib)
and 2.0 ± 0.4mSv (controls, 𝑃 = NS), respectively (Table 1).
Baseline characteristics are summarized in Table 1.
3.2. Total Pulmonary Vein Ostial Diameter and Volume Are
Increased in Patients with AFib. Total PV ostial volume was
significantly increased in patients with AFib as compared to
controls: total PV ostial volume was 8356.7 ± 296.5mm3 in
patients with AFib compared to 7309.02 ± 213.232mm3 in
controls (𝑃 < 0.005, Figure 1(a)). Similarly, total minimal and
maximal ostial PV diameters were significantly increased in
AFib compared to controls (59.2±1.4mm and 85.2±1.3mm
versus 53.3 ± 1.2mm and 76.9 ± 1.1mm, resp.; 𝑃 < 0.001,
Figure 1(b)).
3.3.The Largest Differences in Volumes betweenAFib and Con-
trols Are Found in Superior PVs. In patients with AFib, the
largest PV ostial volume and maximal diameter were mea-
sured in right superior PV (2465.9 ± 860.4mm3 and 22.6 ±
0.6mm, resp., versus 2112.7 ± 544.5mm3 and 21.0 ± 0.6mm
in controls, Figures 2(a) and 2(c); 𝑃 < 0.05). In left superior
PV, volume and diameter were 1989.02 ± 621.5mm3 and
20.2 ± 0.5mm in AFib versus 1720.5 ± 515.6mm3 and
18.9 ± 0.4mm in controls (𝑃 < 0.05, Figures 2(a) and
2(c)). Accordingly, the difference in PV volume betweenAFib
patients and controls was most pronounced in right superior
PV (Δvolume = 14.4%; 𝑃 = 0.015, Figure 2(a)) and left
superior PV (Δvolume = 14.5%; 𝑃 < 0.01). In right inferior
PV, volume was 2117.9 ± 883.9mm3 in AFib versus 1924.4 ±
578.2mm3 in controls (Δvolume = 9.2%; 𝑃 = NS, Figure
2(a)). In right middle PV, volume was 525.0 ± 354.8mm3
in AFib versus 433.6 ± 123.4mm3 in controls (Δvolume =
17.5%; 𝑛 = 22; 𝑃 = NS, Figure 2(a)). In left inferior PV,
volume was 1626.4 ± 544.5mm3 in AFib versus 1522.0 ±
433.7mm3 in controls (Δvolume = 7%; 𝑃 = NS, Figure
2(a)). Ostial volume and maximal diameter of right middle
PVs were slightly increased in AFib as compared to controls:
right middle PV volume was 525.0 ± 354.8mm3 in AFib
versus 433.6±123.4mm3 in controls, while ostial rightmiddle
PV (maximal) diameter was 8.2 ± 0.8mm in AFib versus
6.3 ± 0.5mm2 in controls. However, this difference was not
significant. No difference was observed in minimal PV ostial
diameters between groups (𝑃 = NS, Figure 2(b)).
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Figure 2: (a) Distribution of pulmonary vein (PV) volume (mm3) in patients with atrial fibrillation (AFib) compared to controls with sinus
rhythm (SR). (b) Distribution of minimal pulmonary vein (PV) diameter (mm) in patients with atrial fibrillation (AFib) compared to healthy
controls with sinus rhythm (SR). (c) Distribution of maximal pulmonary vein (PV) diameter (mm) in patients with atrial fibrillation (AFib)
compared to healthy controls with sinus rhythm (SR). LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; RIPV, right
inferior pulmonary vein; RSPV, right superior pulmonary vein; RMPV, right middle pulmonary vein. Data are presented as mean ± SEM;
∗
𝑃 < 0.05.
Conventional PV anatomy, with 4 separate PVs, was
present in 73% of patients (Figure 3). Anatomical variants
were observed more often in patients with AFib (42%) com-
pared to controls (14%, 𝑃 < 0.05). The most common
observed PV variationwas a right-sidedmiddle accessory PV
in 16 patients (32%) with AFib and 7 controls (14%,𝑃 < 0.05);
the second most frequent PV variation was a common left
ostium (LCO) which was present in 4 patients with AFib
Cardiology Research and Practice 5
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Figure 3: (a) Number of patients with a right middle pulmonary vein (RMPV), common left ostium (LCO), and common right ostium
(RCO). Patients with AFib (atrial fibrillation) versus controls with SR (sinus rhythm). 𝑁 = number of patients; total number of patients in
each group = 50. (b) Volume of left atrium after exclusion of the pulmonary veins and left atrial appendage. (b) Left atrial volume in controls
and patients with AFib. (c) Left atrial volume indexed to body surface area (BSA) in controls and patients with AFib; ∗𝑃 < 0.05.
(8%).Nopatients had a left accessory PV, and only one patient
with AFib (2%) had a common right ostium (RCO).
3.4. Left Atrial Volume Is Increased in Patients with AFib.
Left atrial (LA) volume was assessed from prospectively
ECG-gated (75% of RR-interval), contrast-enhanced cardiac
volumes by using 3D volume-rendered images with semiau-
tomated circumference measurement. The mean LA volume
in the total study population was 85.7 ± 18mL with a range
of 37–172mL. LA volume was significantly smaller in control
patients (62.3 ± 161mL) than that in patients with AFib
(111.6 ± 21.3mL, 𝑃 = 0.01). Similarly, LA volume indexed
to body surface area (BSA) was smaller in control patients
(32.26 ± 8.4mL/m2) than in patients with AFib (58.7 ±
10.3mL/m2, 𝑃 = 0.03).
4. Discussion
In this study, we demonstrate that total PV ostial volume
and diameter are significantly increased in patients with drug
refractory AFib compared to controls. This increase in PV
ostial volume and diameter is most pronounced in superior
PVs with the largest difference measured in right superior
PVs. Further, we confirm that PV anatomy is different in
patients with AFib with a higher frequency of right middle
PVs and left common ostium.
Usually, four PVs drain into the left atrium. The superior
PVs enter the left atrium from a superior, anterior, and lateral
direction and the inferior ones from the posterior direction
[15]. It is well known that there is considerable variation in
PV anatomy and anatomical alterations of PVs, including
common ostia, and additional veins have been detected in 18–
45% of patients with AFib. However, the reported frequency
of such anatomical variations has wide dispersion, which
can in part be explained by variability in definitions of
normality, and methodological differences. We observed an
increased incidence of RMPV and LCO in patients with
AFib. This distribution of anatomical variants in our study
is very consistent with prior studies that have reported an
additional RMPV or a LCO more frequently in patients with
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Figure 4: (a–c) Identification and labelling of left atrium and pulmonary vein ostia in 2-dimensional (axial) viewing. (d) Confirmation of
point of inflection between pulmonary vein and left atrial wall in curved multiplanar reconstructions. (e-f) Following clear identification of
ostia, measurement of minimal and maximal ostial pulmonary vein diameter in oblique view. (g-h) Three-dimensional volume-rendered
reconstruction: the previously identified ostium was used as a starting point for volume measurements along the course of the PV to
the midpoint of the PV 1 cm distal of the ostium. (i) Depiction of pulmonary vein anatomy and branching pattern by using 3D volume-
rendered images. (j) Tracing and labelling of left atrium for left atrium volumemeasurements by using 3D rendered images. LIPV, left inferior
pulmonary vein; LSPV, left superior pulmonary vein; RIPV, right inferior pulmonary vein; RSPV, right superior pulmonary vein; RMPV, right
middle pulmonary vein.
AFib compared to controls [16–18]. However, controversies
exist regarding whether right-sided anatomical variants are
associated with a higher risk of AFib recurrence following
radiofrequency catheter ablation.While some studies did not
find a relation between PV anatomy and AFib recurrence,
others reported an increased incidence of AFib recurrence
in normal PV anatomy compared to variant anatomy, or a
higher AFib recurrence rate in anatomical variants [6, 17,
19–24]. Thus, larger clinical studies will be required to est-
ablish whether anatomical variants are a risk factor for AFib
recurrence.
There is clear evidence that enlarged LA dimensions are
more frequently observed in patients with AFib and that
larger LAdimensions are associatedwith a higher risk ofAFib
recurrence following ablation [6, 25]. However, while LA
dimensions have been well described in patients with AFib,
less information is available if such morphological changes
also occur in the PVs. To the best of our knowledge, to date,
no study has measured ostial PV volumes in patients with
AFib and only few studies have directly compared PV char-
acteristics in patients with and without AFib. Consistent with
our results, these authors report larger PV ostial diameters in
patients with AFib compared to controls [10, 16, 20, 26]. Fur-
ther, superior PVs seem to have a larger ostial diameter than
inferior PVs, a phenomenon that was also observed in the
present study [27]. Remarkably, enlargement of superior PVs
has been described to be an independent risk factor for AFib
recurrence following radiofrequency catheter ablation [28].
Previous investigators have measured PV diameters by
using CT only in one specified plane, usually at the ostium
in anterior-posterior and inferior-superior directions [10]. It
is often difficult to define the border between left atrium and
pulmonary veins by 2D analysis; thus, we used 3D recon-
structed models and performed volume measurements in all
PVs starting from the point of inflection between the PV and
atrial wall along the course of the PV to the midpoint of the
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PV 1 cm distally of the ostium. In addition, we used oblique
and curved multiplanar reconstructions to confirm the bor-
ders of both left atrium and PVs. Since PV ostia are consid-
ered to have an elliptical shape with the long axis in vertical
orientation [29], 3D measurement and calculation of PV
areas and volumesmay copemore precisely with the elliptical
shape of the ostia and may be a more suitable diagnostic
tool to detect anatomical differences in AFib compared with
diameter measurements and may improve diagnostic accu-
racy.
Limitations of this study are its retrospective design
limited to a single center experience. Further, the study popu-
lation size is limited, which is in part counterbalanced by
optimal matching of the control group. In addition, the prog-
nostic value of our findings remains to be elucidated, and fur-
ther studies are needed to assess whether the observed alter-
ations in PV anatomy contribute to the complex pathophy-
siology of AFib or whether larger PV ostia are a cause, a con-
sequence, or just an epiphenomenon of atrial structural
remodelling in AFib.
In conclusion, we found that PV ostial diameter and
PV volume were significantly larger in patients with drug
refractory AFib than in controls and that this difference was
most pronounced in right superior PVs.This finding suggests
that an assessment of PV ostial volume may add to the risk
stratification for AFib recurrence following RFCA and may
be incorporated into the preprocedural evaluation of patients
being considered for AFib ablation.
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